Growth Metrics

Harmony Biosciences Holdings (HRMY) Total Debt (2019 - 2025)

Historic Total Debt for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $168.5 million.

  • Harmony Biosciences Holdings' Total Debt fell 784.32% to $168.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $168.5 million, marking a year-over-year decrease of 784.32%. This contributed to the annual value of $179.3 million for FY2024, which is 738.77% down from last year.
  • Harmony Biosciences Holdings' Total Debt amounted to $168.5 million in Q3 2025, which was down 784.32% from $172.1 million recorded in Q2 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' Total Debt peaked at $197.1 million during Q3 2023, and registered a low of $168.5 million during Q3 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' median Total Debt value was $191.6 million (recorded in 2022), while the average stood at $187.9 million.
  • In the last 5 years, Harmony Biosciences Holdings' Total Debt soared by 281.97% in 2023 and then crashed by 784.32% in 2025.
  • Harmony Biosciences Holdings' Total Debt (Quarter) stood at $192.0 million in 2021, then decreased by 0.18% to $191.6 million in 2022, then rose by 1.0% to $193.6 million in 2023, then decreased by 7.39% to $179.3 million in 2024, then fell by 6.0% to $168.5 million in 2025.
  • Its Total Debt was $168.5 million in Q3 2025, compared to $172.1 million in Q2 2025 and $175.7 million in Q1 2025.